Posttranslational Modifications of Unconventional Autoantigens: Shaping Immunogenicity and Inflammatory Activity
Immunological Reviews · 2026-11 · 344 (1)
DOI: 10.1111/imr.70186 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 04.11.2026. Verfasst von Roberto Lande und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy. Hauptthemen laut MEDLINE: Autoantigens, Protein Processing, Post-Translational, Inflammation. Die Arbeit nennt 112 Literaturangaben. Gefördert von: FOREUM, CH, National Psoriasis Foundation (USA), Foundation for Research in Rheumatology.
Abstract (Originalsprache)
Posttranslational modifications (PTMs) of self‐antigens precipitate autoimmunity by generating neo‐epitopes that breach tolerance and activate autoreactive T and B cells. This review spotlights cathelicidin LL37 and chemokine CXCL4 (PF4) in psoriatic disease (psoriasis and psoriatic arthritis, PSO and PSA), systemic lupus erythematosus (SLE), and systemic sclerosis (SSc), drawing on key studies including our own. Uniquely, unlike most autoantigens, LL37 and CXCL4 exert a dual role: they are immunogenic targets for T and B cells while directly fueling innate inflammation. Through chaperone‐like binding to self‐ and microbial DNA/RNA, they form complexes that potently stimulate plasmacytoid and myeloid dendritic cells (pDCs/mDCs) via DNA/RNA sensors, such as TLR7‐9 and cGAS/STING, driving Type I interferon and cytokines storms. Strikingly, these complexes also induce B cells to become antibody‐producing plasma cells, amplifying adaptive responses and likely suppressing regulation. Here, we detail the role of PTM‐modified LL37 in PSO, PSA, and SLE—forming autoantigenic neutrophil extracellular traps—and CXCL4 in SSc, where it acts as biomarker and autoantibody target. Our work underscores how this dual functionality as “bifunctional autoantigens” exacerbates disease, and how PTMs modification influence these phenomena. These molecules and their PTM can be targeted to halt inflammatory cascades and restore tolerance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.
ORCID-Profile: Anna Mennella, Loredana Frasca
Förderung
- FOREUM, CH
- National Psoriasis Foundation (USA)
- Foundation for Research in Rheumatology
Zitieren
APA
Lande, R., Mennella, A., Palazzo, R., & Frasca, L. (2026). Posttranslational Modifications of Unconventional Autoantigens: Shaping Immunogenicity and Inflammatory Activity. Immunological Reviews, 344(1). https://doi.org/10.1111/imr.70186
Vancouver
Lande R, Mennella A, Palazzo R, Frasca L. Posttranslational Modifications of Unconventional Autoantigens: Shaping Immunogenicity and Inflammatory Activity. Immunological Reviews. 2026;344(1). doi:10.1111/imr.70186
BibTeX
@article{Lande2026,
author = {Lande, Roberto and Mennella, Anna and Palazzo, Raffaella and Frasca, Loredana},
title = {Posttranslational Modifications of Unconventional Autoantigens: Shaping Immunogenicity and Inflammatory Activity},
journal = {Immunological Reviews},
year = {2026},
volume = {344},
number = {1},
doi = {10.1111/imr.70186}
}
EUVIMED